BR6351350D0 - Um processo para a estabilizacao de materiais de virus antigenos labeis - Google Patents

Um processo para a estabilizacao de materiais de virus antigenos labeis

Info

Publication number
BR6351350D0
BR6351350D0 BR151350/63A BR15135063A BR6351350D0 BR 6351350 D0 BR6351350 D0 BR 6351350D0 BR 151350/63 A BR151350/63 A BR 151350/63A BR 15135063 A BR15135063 A BR 15135063A BR 6351350 D0 BR6351350 D0 BR 6351350D0
Authority
BR
Brazil
Prior art keywords
viruses
stabilization
materials
label antigens
antigens
Prior art date
Application number
BR151350/63A
Other languages
English (en)
Portuguese (pt)
Inventor
W Rightsel
E Schuler
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of BR6351350D0 publication Critical patent/BR6351350D0/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR151350/63A 1962-08-16 1963-08-01 Um processo para a estabilizacao de materiais de virus antigenos labeis BR6351350D0 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US217293A US3186908A (en) 1962-08-16 1962-08-16 Calcium lactobionate stabilization of labile antigenic virus vaccine materials

Publications (1)

Publication Number Publication Date
BR6351350D0 true BR6351350D0 (pt) 1973-08-02

Family

ID=22810442

Family Applications (1)

Application Number Title Priority Date Filing Date
BR151350/63A BR6351350D0 (pt) 1962-08-16 1963-08-01 Um processo para a estabilizacao de materiais de virus antigenos labeis

Country Status (10)

Country Link
US (1) US3186908A (enExample)
BR (1) BR6351350D0 (enExample)
CH (1) CH412201A (enExample)
DE (1) DE1227615B (enExample)
DK (1) DK104193C (enExample)
ES (1) ES290512A1 (enExample)
FI (1) FI40108C (enExample)
FR (1) FR1594506A (enExample)
GB (1) GB1049386A (enExample)
SE (1) SE314774B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4380582A (en) * 1965-07-09 1983-04-19 The United States Of America As Represented By The Secretary Of The Army Preparation of dry variola virus
DE1617457A1 (de) * 1966-12-16 1972-04-20 Erba Carlo Spa Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin
JPS5716823A (en) * 1980-07-03 1982-01-28 Green Cross Corp:The Live mumps vaccine pharmaceutical and stabilizing method
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
CN116115766B (zh) * 2023-02-06 2024-04-09 广东永顺生物制药股份有限公司 一种活疫苗耐热冻干保护剂及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA603832A (en) * 1960-08-23 J. Scott William Method and means for the dried storage of micro-organisms
US2186975A (en) * 1933-04-10 1940-01-16 Horace S Isbell Crystalline calcium lactobionate calcium bromide and process for making the same
GB716920A (en) * 1951-07-31 1954-10-20 Andre Jean Pierre Joseph Thoma A process for the mass production and treatment of pathogenic viruses and substances which accompany them
US2879202A (en) * 1954-11-05 1959-03-24 American Cyanamid Co Stabilization of live viral vaccines by hexahydric alcohols
US2912361A (en) * 1956-11-28 1959-11-10 Sterling Drug Inc Canine distemper vaccine and its preparation
US2946724A (en) * 1957-05-29 1960-07-26 American Cyanamid Co Stable poliomyelitis live virus vaccine
GB899011A (en) * 1958-03-14 1962-06-20 Upjohn Co Rubeola vaccine and process
US3031378A (en) * 1959-05-30 1962-04-24 Ishidate Morizo Method of inactivating viruses
GB900115A (en) * 1960-06-15 1962-07-04 Armour & Co Improvements in or relating to trypsin solutions

Also Published As

Publication number Publication date
DK104193C (da) 1966-04-18
FR1594506A (enExample) 1970-06-08
CH412201A (fr) 1966-04-30
DE1227615B (de) 1966-10-27
ES290512A1 (es) 1963-11-16
GB1049386A (en) 1966-11-23
SE314774B (enExample) 1969-09-15
FI40108B (enExample) 1968-06-28
US3186908A (en) 1965-06-01
FI40108C (fi) 1968-10-10

Similar Documents

Publication Publication Date Title
BR6568986D0 (pt) Processo para preparar compostos de hidroxiboroxin-amina e composicoes lubrificantes contendo os mesmos
BR6569792D0 (pt) Processo para a preparacao de alcanais e alcanois fenoxi substituidos
BR6569567D0 (pt) Processo para preparar novos compostos quimicos e processo para preparar composicoes antelminticas contendo esses compostos
BR6458616D0 (pt) Processo para preparacao de tioxanteno-sulfanamidas
BR6353917D0 (pt) Processo para preparacao de novos compostos de (3-substituido pirazinamido) guanidina
BR6352419D0 (pt) Processo para a preparacao de novos compostos heterociclicos
BR6352674D0 (pt) Processo para a preparacao de poli-p-benzamida
BR6352520D0 (pt) Processo para a preparacao de composicoes vitaminadas
BR6570214D0 (pt) Processo para preparacao de compostos anti-virus
BR6349262D0 (pt) Processo para a preparacao de compostos 2-guanidino-alcoil-1 4-benzo-dioxanicos
BR6457033D0 (pt) Um processo para a preparacao de aminoacetil-penicilinas
BR6461880D0 (pt) Processo para a preparacao de um 2-guanidino-alcoil-cromano
BR6569828D0 (pt) Esteres fenolicos processo de preparacao dos mesmos e composicoes farmaceuticas contendo esses compostos
BR6236106D0 (pt) Processo para a preparacao de inseticidas
BR6353616D0 (pt) Processo para a preparacao de l-alfa-metil-3,4-diidroxi- fenil-alamina
BR6574419D0 (pt) Um processo para a preparacao de composicoes antelmintica
BR6567347D0 (pt) Processo para a preparacao de imidazolidinas substituidas e composicoes herbicidas contendo as mesmas
BR6352357D0 (pt) Processo para a preparacao de novos compostos aril tetralilicos
BR6352733D0 (pt) Processo para a preparacao de dibenzo-ciclo-heptenos
BR6348630D0 (pt) Processo para a preparacao de 17-oxigenio 2-azaandrostano-3-onas e compostos correlacionados
BR6457198D0 (pt) Processo para a preparacao de compostos de diaminoetano n,n'-substituidos
BR6461413D0 (pt) Processo para a preparacao de amino-isoxazois
BR6346524D0 (pt) Processo para a preparacao de alfa-aminobenzil-penicilina
BR6351537D0 (pt) Processo continuo para preparo de virus interferente
BR6460306D0 (pt) Processo para a preparacao de compostos benzimidazolicos